← FDA DRUG APPROVALS

FDA ANDA · ANDA065276

CEFPROZIL

Sponsor: LUPIN

APPLICATION
ANDA065276
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-08
LATEST ACTION
2018-04-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CEFPROZILPrescription
CEFPROZIL 500MG · TABLET · ORAL
CEFPROZILPrescription
CEFPROZIL 250MG · TABLET · ORAL

Approval history

2018-04-09Labeling · Supplement 9 · standardAP
2008-01-16Labeling · Supplement 3AP
2005-12-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →